Startseite > Publikationen > Wiss. Publikationen

Wissenschaftliche Publikationen(Headline)

Ausgewählte Veröffentlichungen (seit 2004)

Schneider, R. (submitted). Low-frequency vibrotherapy (Cellconnect Impulse) considerably improves the effectiveness of manual lymphatic drainage (MLD) in patients with lipedema: A two-armed, randomized, controlled pragmatic trial.

Singer, N. & Schneider, R. (in press). Investigating the use of a specially formulated odour inhaler (AromaStick®) on weight loss: Overview of the results of a two-armed, randomised, controlled effectiveness study. International Journal of Clinical Aromatherapy.

Schneider, R. & Walach, H. (im Druck). Der Placebo-Effekt in der Neuraltherapie - Hoffnung und Zuversicht. In S. Weinschenk (Hrsg.), Leitfaden Neuraltherapie. Zweite Auflage. Stuttgart: Urban & Fischer.

Schneider, R. (in press). Seasonal allergic rhinitis is effectively assuaged with an essential oil inhaler (AromaStick®): Results from a randomized, controlled, double-blind effectiveness trial.

Schneider, R. (in press). A breath of fresh air: Blood oxygen saturation is increased upon the use of an essential oil inhaler (AromaStick®). Results from a prospective, controlled, experimental study involving healthy individuals. Current Drug Delivery.

Schneider, R. (2017). Effectiveness of myofascial trigger point therapy in chronic back pain patients is considerably increased when combined with a new, integrated, low-frequency shock wave vibrotherapy (Cellconnect Impulse): A two-armed, measurement repeated, randomized, controlled pragmatic trial. Journal of Back and Musculoskeletal Rehabilitation, 31.

Schneider, R. (2017). From pain to pleasure: A newly developed essential oil inhaler (AromaStick®) alters pain dynamics and increases well-being. Results from two randomized, controlled documentation studies. Current Psychopharmacology, 6.

Singer, N. & Schneider, R. (2017). Practically relevant stress relieving effects of olfactory stimuli delivered by a specially formulated odour inhaler (AromaStick®): Overview of an initial series of studies testing different boundary conditions. International Journal of Clinical Aromatherapy, 11, 48-58.

Schneider, R. (2016). Direct application of specially formulated scent compositions (AromaStick®) prolongs attention and enhances visual scanning speed. Applied Cognitive Psychology, 30, 650-654.

Schneider, R. (2016). There is something in the air: Testing the efficacy of a new olfactory stress relief method (AromaStick®). Stress & Health, 32, 411-426.

Schneider, R. (2015). Getting in sync: A new ready-to-use biofield resonance device (Vita Chip) reduces chronic pain and increases wellbeing. Neuroscience and Biomedical Engineering, 3, 85-93.

Schneider, R. (2012). Unspecific effects of caffeine consumption: When does the mind overrule the body? In F. D. Romano and P. F. Russo (Eds.), Caffeine Consumption and Health (pp. 123-140). New York: Nova Science Publishers.

Schneider, R. & Kuhl, J. (2012). Placebo forte: Ways to maximize unspecific treatment effects. Medical Hypotheses, 78, 744-751.

Placebo in der Medizin (2011). Herausgegeben von der Bundesärztekammer auf Empfehlung ihres Wissenschaftlichen Beirats. Köln: Deutscher Ärzteverlag.

Büchel, C., Kiefaber, U., Jütte, R., Michaelis, J., Remschmidt, H., Schneider, R., Scriba, P., Tag, B., Türmann P., Weihrauch, T., Witt, C. & Zipfel, S. (2010). Stellungnahme des Wissenschaftlichen Beirats der Bundesärztekammer "Placebo in der Medizin". Deutsches Ärzteblatt 107, A1417-A1421. [PDF]

Schneider, R. & Walach, H. (2010). Der Placebo-Effekt in der Neuraltherapie - Hoffnung und Zuversicht. In S. Weinschenk (Hrsg.), Leitfaden Neuraltherapie (S. 182-184). Stuttgart: Urban & Fischer.

Schneider, R. (2009). Unspecific effects of caffeine consumption: When does the mind overrule the body? In K. B. Chambers (Ed.), Caffeine and Health Research (pp. 143-160). New York: Nova Science Publishers. [PDF]

Möllinger, H., Schneider, R., & Walach, H. (2009). Homeopathic pathogenetic trials produce specific symptoms different from placebo. Forschende Komplementärmedizin und Klassische Naturheilkunde, 16, 105-110. [PDF]

Walach, H. & Schneider, R. (2009). Does the presence of a pharmacological substance alter the placebo effect? - Results of two experimental studies using the placebo-caffeine paradigm. Human Psychopharmacology: Clinical and Experimental, 24, 549-558. [PDF]

Walach, H., Möllinger, H., Sherr, J., & Schneider, R. (2008). Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials. Journal of Psychopharmacology, 22, 543-552. [PDF]

Mutter J., Naumann J., Schneider R., & Walach H. (2007). Quecksilber und Alzheimer-Erkrankung. Fortschritte der Neurologie Psychiatrie, 75, 1-13. [PDF]

Ross, T., Fontao, M. I., & Schneider, R. (2007). Aggressive behavior in male offenders: Preliminary analyses of self-regulatory functions in a sample of criminals. Psychological Reports, 100, 1171-1185.

Schneider, R. (2007). The psychology of the placebo effect: Exploring meaning from a functional account. Journal of Mind and Behavior, 28, 1-17. [PDF]

Mutter, J., Naumann, J., Schneider, R., Walach, H. & Haley, B. (2006). Quecksilber und Autismus: Zunehmende Beweise? Umwelt-Medizin-Gesellschaft, 19, 77-84.

Schneider R., Grüner M., Heiland A., Keller M., Kujanová Z., Peper M., Riegl M., Schmidt S., Volz P., & Walach H. (2006). Effects of expectation and caffeine on well-being, arousal, and reaction time. International Journal of Behavioral Medicine, 13, 330-339. [PDF]

Schneider, R., & Walach, H. (2006). Randomized double-blind pilot study on psychological effects of a treatment with "Instrumental Biocommunication". Forschende Komplementärmedizin und Klassische Naturheilkunde, 13, 35-40. [PDF]

Mutter, J., Naumann, J., Sadaghiani, C., Schneider, R. & Walach H. (2005). Die Alzheimer-Krankheit: Quecksilber als pathogener Faktor und Apoliprotein E als Moderator. Umwelt-Medizin-Gesellschaft, 18, 59-66.

Mutter, J., Naumann, J., Schneider, R., Walach, H., & Haley B. (2005). Mercury and autism: Accelerating Evidence? Neuroendocrinology Letters, 26, 439-446.

Schneider R. (2005). Placeboeffekt und Bedeutung – Eine funktionalpsychologische Betrachtung. Psychologische Rundschau, 56, 201-209. [PDF]

Möllinger, H., Schneider, R., Löffel, M., & Walach, H. (2004). A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: Comparing two high potencies. Forschende Komplementärmedizin und Klassische Naturheilkunde, 11, 274-280.

Mutter, J., Naumann, J., Sadaghiani, C., Schneider, R., & Walach H. (2004). Alzheimer Disease: Mercury as pathogenetic factor and apolipoprotein E as moderator. Neuroendocrinology Letters, 5, 275-283.

Schneider, R., Kuhl, J., & Walach, H. (2004). From justification to discovery: A conditional testing approach to unorthodox forms of interpersonal interaction. Personality and Individual Differences, 36, 509-525. [PDF]